7,8-Dihydroxyflavone inhibits adipocyte differentiation via antioxidant activity and induces apoptosis in 3T3-L1 preadipocyte cells

Life Sci. 2016 Jan 1:144:103-12. doi: 10.1016/j.lfs.2015.11.028. Epub 2015 Dec 2.

Abstract

Aims: Anti-obesity effects of a natural plant flavonoid 7,8-dihydroxyflavone (7,8-DHF) were evaluated using 3T3-L1 preadipocyte cells.

Main methods: The cell viability was determined using MTT assay. Effects of 7,8-DHF on intracellular lipid droplets and intracellular reactive oxygen species (ROS) were measured using a 2,7-dichlorofluorescein diacetate (DCF-DA) assay and Oil Red O staining method, respectively. Apoptotic cell death was monitored by annexin V-FITC/PI double staining and by a TUNEL assay. Antioxidant enzyme mRNA levels and protein expression of adipogenic transcription factors were determined by real-time PCR and Western blotting, respectively.

Key findings: Whereas the cell viability of 3T3-L1 preadipocytes was not affected by lower concentrations of 7,8-DHF (<20 μM), higher concentrations of 7,8-DHF (>20 μM) induced apoptotic cell death. 7,8-DHF (<20 μM) significantly reduced the intracellular lipid droplets and the expression of major adipogenic transcription factors, such as CCAAT/enhancer-binding protein-α (C/EBP-α), C/EBP-β, and peroxisome proliferator activated receptor-γ (PPAR-γ). 7,8-DHF treatment also dose-dependently reduced the intracellular ROS level, attenuated MAPK pathway activation, and increased the expression of antioxidant enzymes, such as Mn-superoxide dismutase (Mn-SOD), catalase (CAT), and heme oxygenase-1 (HO-1).

Significance: The results of this study indicated that 7,8-DHF inhibits the adipogenesis of 3T3-L1 preadipocyte cells by down-regulating the expression of adipogenic transcription factors, reduces lipid accumulation, and attenuates ROS accumulation by inducing antioxidant enzymes in differentiated 3T3-L1 cells, suggesting for the first time that 7,8-DHF has an anti-obesity effect in vitro via its anti-oxidant activity.

Keywords: 7,8-Dihydroxyflavone; Adipocyte; Anti-obesity; Antioxidant; Differentiation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3T3-L1 Cells
  • Adipocytes / drug effects*
  • Adipogenesis / drug effects
  • Adipogenesis / genetics
  • Animals
  • Anti-Obesity Agents / pharmacology*
  • Antioxidants / metabolism*
  • Antioxidants / pharmacology*
  • Apoptosis / drug effects*
  • Cell Differentiation / drug effects
  • Cell Survival / drug effects
  • Dose-Response Relationship, Drug
  • Flavones / pharmacology*
  • Free Radical Scavengers / pharmacology
  • In Situ Nick-End Labeling
  • Lipid Metabolism / drug effects
  • Mice
  • RNA, Messenger / biosynthesis
  • Reactive Oxygen Species / metabolism

Substances

  • 6,7-dihydroxyflavone
  • Anti-Obesity Agents
  • Antioxidants
  • Flavones
  • Free Radical Scavengers
  • RNA, Messenger
  • Reactive Oxygen Species